| Jorge Thomas Vournas, MD | |
|
4101 Torrance Blvd, Em Dept, Torrance, CA 90503-4607 | |
| (310) 540-7676 | |
| (405) 751-3183 |
| Full Name | Jorge Thomas Vournas |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 30 Years |
| Location | 4101 Torrance Blvd, Torrance, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073558235 | NPI | - | NPPES |
| 00A560350 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | A56035 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Little Company Of Mary Med Ctr Torrance | Torrance, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Specialist Physicians Medical Associates, Inc | 2163329822 | 34 |
News Archive
Online social networks could help with communications and recovery for people with disabilities following major natural disasters, or even terrorist attack, according to a research paper in the International Journal of Emergency Management.
A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.
Centocor Ortho Biotech Products, L.P. today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for trabectedin when administered in combination with DOXIL(R) (doxorubicin HCI liposome injection) for the treatment of women with relapsed ovarian cancer.
SIRO Clinpharm, a global Contract Research Organization (CRO) with bases in India, US, Europe and Israel today announced their alliance with Mediscis, an early drug development company based in Poitiers and La Rochelle, France.
Xenotropic murine leukemia virus-related virus (XMRV) has been the subject of many studies since its discovery in 2006, but conflicting reports have created an unclear picture of XMRV's role in human disease. In three recent studies published in the November 15 issue of The Journal of Infectious Diseases, now available online, the evidence supports a possible link between XMRV and prostate cancer but not other links involving chronic fatigue syndrome, HIV infection, or hepatitis C virus (HCV) infection.
› Verified 4 days ago
| Entity Name | Emergency Specialist Physicians Medical Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518917913 PECOS PAC ID: 2163329822 Enrollment ID: O20031218001027 |
News Archive
Online social networks could help with communications and recovery for people with disabilities following major natural disasters, or even terrorist attack, according to a research paper in the International Journal of Emergency Management.
A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.
Centocor Ortho Biotech Products, L.P. today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for trabectedin when administered in combination with DOXIL(R) (doxorubicin HCI liposome injection) for the treatment of women with relapsed ovarian cancer.
SIRO Clinpharm, a global Contract Research Organization (CRO) with bases in India, US, Europe and Israel today announced their alliance with Mediscis, an early drug development company based in Poitiers and La Rochelle, France.
Xenotropic murine leukemia virus-related virus (XMRV) has been the subject of many studies since its discovery in 2006, but conflicting reports have created an unclear picture of XMRV's role in human disease. In three recent studies published in the November 15 issue of The Journal of Infectious Diseases, now available online, the evidence supports a possible link between XMRV and prostate cancer but not other links involving chronic fatigue syndrome, HIV infection, or hepatitis C virus (HCV) infection.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jorge Thomas Vournas, MD 4401 W Memorial Rd, Suite 121, Oklahoma City, OK 73134-1785 Ph: (405) 751-4664 | Jorge Thomas Vournas, MD 4101 Torrance Blvd, Em Dept, Torrance, CA 90503-4607 Ph: (310) 540-7676 |
News Archive
Online social networks could help with communications and recovery for people with disabilities following major natural disasters, or even terrorist attack, according to a research paper in the International Journal of Emergency Management.
A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.
Centocor Ortho Biotech Products, L.P. today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for trabectedin when administered in combination with DOXIL(R) (doxorubicin HCI liposome injection) for the treatment of women with relapsed ovarian cancer.
SIRO Clinpharm, a global Contract Research Organization (CRO) with bases in India, US, Europe and Israel today announced their alliance with Mediscis, an early drug development company based in Poitiers and La Rochelle, France.
Xenotropic murine leukemia virus-related virus (XMRV) has been the subject of many studies since its discovery in 2006, but conflicting reports have created an unclear picture of XMRV's role in human disease. In three recent studies published in the November 15 issue of The Journal of Infectious Diseases, now available online, the evidence supports a possible link between XMRV and prostate cancer but not other links involving chronic fatigue syndrome, HIV infection, or hepatitis C virus (HCV) infection.
› Verified 4 days ago
Dr. Gina L Sulmeyer, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3330 Lomita Blvd, Torrance, CA 90505 Phone: 310-517-4785 | |
Dr. Manpreet Singh, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 W Carson St, Torrance, CA 90502 Phone: 310-222-3501 Fax: 310-782-1763 | |
Ryan Gleber, MD, BS Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3330 Lomita Blvd, Torrance, CA 90505 Phone: 310-325-9110 | |
Dr. Daena Sarah Watcha, MD, MS Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 W Carson St, Torrance, CA 90502 Phone: 310-222-3501 Fax: 310-782-1763 | |
Mary Sun, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3330 Lomita Blvd, Dept Of Emergency Medicine, Torrance, CA 90505 Phone: 310-717-6381 | |
Robert L.r. Gibbs, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 24325 Crenshaw Blvd, # 283, Torrance, CA 90505 Phone: 424-777-6642 Fax: 877-223-4535 | |
Dr. Shannon M Stacy, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3330 Lomita Blvd, Torrance Memorial Medical Center, Torrance, CA 90505 Phone: 310-325-9110 |